Detalhe da pesquisa
1.
Evaluating the Impact of ESPAC-1 on Shifting the Paradigm of Pancreatic Cancer Treatment.
J Surg Res
; 259: 442-450, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33059910
2.
Immune checkpoint inhibitors in liver transplant: a case series.
J Gastrointest Oncol
; 14(2): 1141-1148, 2023 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37201081
3.
Rational polypharmacological targeting of FLT3, JAK2, ABL, and ERK1 suppresses the adaptive resistance to FLT3 inhibitors in AML.
Blood Adv
; 7(8): 1460-1476, 2023 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36044389
4.
Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial.
Nat Med
; 29(4): 869-879, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37069359
5.
Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19.
JAMA Oncol
; 9(10): 1390-1400, 2023 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37589970
6.
Momelotinib is a highly potent inhibitor of FLT3-mutant AML.
Blood Adv
; 6(4): 1186-1192, 2022 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34768286
7.
Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19.
Blood Cancer Discov
; 3(3): 181-193, 2022 05 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35262738
8.
Patterns of Failure After Neoadjuvant Stereotactic Body Radiation Therapy or Fractionated Chemoradiation in Resectable and Borderline Resectable Pancreatic Cancer.
Pancreas
; 49(7): 941-946, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32658077
9.
Pattern of Marginal Local Failure in a Phase II Trial of Neoadjuvant Chemotherapy and Stereotactic Body Radiation Therapy for Resectable and Borderline Resectable Pancreas Cancer.
Am J Clin Oncol
; 42(3): 247-252, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30724781
10.
Downstaging therapy followed by liver transplantation for hepatocellular carcinoma beyond Milan criteria.
Surgery
; 162(6): 1250-1258, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29033224
11.
Targeting c-FOS and DUSP1 abrogates intrinsic resistance to tyrosine-kinase inhibitor therapy in BCR-ABL-induced leukemia.
Nat Med
; 23(4): 472-482, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28319094
12.
Advances in multiple myeloma and spine disease.
Clin Lymphoma Myeloma
; 6(3): 228-33, 2005 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-16354328
13.
Imaging and Therapy of Pancreatic Cancer with Phosphatidylserine-Targeted Nanovesicles.
Transl Oncol
; 8(3): 196-203, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26055177
14.
Influence of Rituximab on Central Nervous System Relapse in Diffuse Large B-Cell Lymphoma and Role of Prophylaxis--A Systematic Review of Prospective Studies.
Clin Lymphoma Myeloma Leuk
; 15(8): 451-7, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25816933
15.
Prophylactic CNS directed therapy in systemic diffuse large B cell lymphoma.
Crit Rev Oncol Hematol
; 91(3): 292-303, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24698003
16.
Thalidomide and its analogues in the treatment of Multiple Myeloma.
Exp Hematol Oncol
; 1(1): 27, 2012 Sep 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-23210501
17.
The biology of myelodysplastic syndromes: unity despite heterogeneity.
Hematol Rep
; 2(1): e4, 2010 Jan 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-22184517
18.
Lymphoma presenting as secondary HLH: a review with a tale of two cases.
Clin Lymphoma Myeloma Leuk
; 14(6): e187-93, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25065778
19.
Phase II study of oral bis (aceto) ammine dichloro (cyclohexamine) platinum (IV) (JM-216, BMS-182751) given daily x 5 in hormone refractory prostate cancer (HRPC).
Invest New Drugs
; 23(1): 79-84, 2005 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-15528984